Co-Authors
This is a "connection" page, showing publications co-authored by Alex Soriano and Celia Cardozo.
Connection Strength
1.885
-
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection. Rev Esp Quimioter. 2021 Jun; 34(3):238-244.
Score: 0.235
-
Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia. J Clin Med. 2019 Aug 01; 8(8).
Score: 0.209
-
Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study. Antimicrob Agents Chemother. 2018 11; 62(11).
Score: 0.198
-
[Clinical features and outcome in patients with mucormycosis in a tertiary hospital (2012-2016)]. Rev Iberoam Micol. 2018 Jul - Sep; 35(3):162-166.
Score: 0.197
-
Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis. J Infect. 2018 04; 76(4):342-347.
Score: 0.188
-
Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019. Clin Infect Dis. 2022 01 07; 74(1):127-132.
Score: 0.062
-
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. J Antimicrob Chemother. 2021 11 12; 76(12):3296-3302.
Score: 0.061
-
Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study. BMJ Open. 2021 08 17; 11(8):e040775.
Score: 0.060
-
Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19. Infect Dis Ther. 2021 Sep; 10(3):1407-1418.
Score: 0.059
-
Experience with the use of siltuximab in patients with SARS-CoV-2 infection. Rev Esp Quimioter. 2021 Aug; 34(4):337-341.
Score: 0.059
-
Real-life use of remdesivir in hospitalized patients with COVID-19. Rev Esp Quimioter. 2021 Apr; 34(2):136-140.
Score: 0.058
-
Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain. Lancet Reg Health Eur. 2021 Apr; 3:100041.
Score: 0.058
-
Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome. Int J Infect Dis. 2021 Mar; 104:164-168.
Score: 0.057
-
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021 Jan; 27(1):83-88.
Score: 0.056
-
Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam. Int J Antimicrob Agents. 2019 Apr; 53(4):520-524.
Score: 0.050
-
Top-ten papers in fungal infection (2015-2017). Rev Esp Quimioter. 2018 Sep; 31 Suppl 1:32-34.
Score: 0.049
-
Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies. Clin Microbiol Infect. 2019 Apr; 25(4):447-453.
Score: 0.049
-
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa. J Glob Antimicrob Resist. 2018 12; 15:136-139.
Score: 0.049
-
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis-authors' response. J Antimicrob Chemother. 2018 06 01; 73(6):1732-1733.
Score: 0.048
-
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: a propensity score-adjusted and matched analysis. J Antimicrob Chemother. 2017 Dec 01; 72(12):3443-3452.
Score: 0.047
-
Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients. Antimicrob Agents Chemother. 2014 Jul; 58(7):4180-4.
Score: 0.036